The global rapid diagnostic kits market is expected to grow at a CAGR of 6.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of infectious diseases and rising demand for point-of-care testing in developing countries. Rapid diagnostic kits are used for detecting various types of infections such as HIV, malaria, hepatitis B and C, tuberculosis (TB), dengue fever, chikungunya virus infection and others. Rapid diagnostic kits are also used for detecting pregnancy status and blood type in hospitals and clinics.
Rapid diagnostic kits are classified into lateral flow test (LFT), agglutination assays (AA) or flow through (FT) or solid phase assay (SPA). LFTs detect antibodies against specific pathogens by using antigen-antibody reactions on a strip that has been dipped into a sample containing the pathogen's antigens; AA detects antibodies against specific pathogens by using antigen-antibody reactions on a slide that has been dipped into a sample containing the pathogen's antigens; FTs detect antibodies against specific pathogens by using antigen-antibody reactions on an absorbent pad that has been dipped into a sample containing the pathogen's antigens; SPAs detect antibodies against specific pathogens by using antigen-antibody reactions on an absorbent pad that has been dipped into a sample containing the pathogen's antigens.
Hospitals & clinical testing segment accounted for more than 50% share in 2017 owing to increasing number of patients with chronic diseases such as diabetes mellitus type 2 which require regular monitoring at hospitals & clinics which leads to increased use of rapid diagnostics tests in these settings. Home testing segment is expected to grow at highest CAGR during forecast period owing to growing awareness about health issues among people coupled with rising disposable income leading them towards self diagnosis methods like home testing kit usage which can be done without any medical supervision or guidance from healthcare professionals.
Rapid Diagnostic Kits are used to diagnose diseases and other medical conditions. The market for Rapid Diagnostic Kits is expected to grow due to the increasing number of people with chronic diseases, such as diabetes, cancer, and heart disease.
Industry Growth Insights published a new data on “Rapid Diagnostic Kits Market”. The research report is titled “Rapid Diagnostic Kits Market research by Types (Lateral Flow Test, Agglutination Assays, Flow Through, Solid Phase), By Applications (Hospitals and Clinical Testing, Home Testing, Veterinary Testing, Other), By Players/Companies Abbott Laboratories, Alfa Scientific Designs, Artron Laboratories, BD, Meridian Bioscience, ACON Laboratories, Creative Diagnostics, BTNX, McKesson, Roche, Zoetis, BioMerieux”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Rapid Diagnostic Kits Market Research Report
By Type
Lateral Flow Test, Agglutination Assays, Flow Through, Solid Phase
By Application
Hospitals and Clinical Testing, Home Testing, Veterinary Testing, Other
By Companies
Abbott Laboratories, Alfa Scientific Designs, Artron Laboratories, BD, Meridian Bioscience, ACON Laboratories, Creative Diagnostics, BTNX, McKesson, Roche, Zoetis, BioMerieux
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Rapid Diagnostic Kits Market Report Segments:
The global Rapid Diagnostic Kits market is segmented on the basis of:
Types
Lateral Flow Test, Agglutination Assays, Flow Through, Solid Phase
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinical Testing, Home Testing, Veterinary Testing, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Alfa Scientific Designs
- Artron Laboratories
- BD
- Meridian Bioscience
- ACON Laboratories
- Creative Diagnostics
- BTNX
- McKesson
- Roche
- Zoetis
- BioMerieux
Highlights of The Rapid Diagnostic Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Lateral Flow Test
- Agglutination Assays
- Flow Through
- Solid Phase
- By Application:
- Hospitals and Clinical Testing
- Home Testing
- Veterinary Testing
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rapid Diagnostic Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rapid diagnostic kits (RKs) are a type of medical kit that is used to diagnose diseases and injuries. RKs include items such as test strips, syringes, and other tools needed for diagnosing diseases.
Some of the major players in the rapid diagnostic kits market are Abbott Laboratories, Alfa Scientific Designs, Artron Laboratories, BD, Meridian Bioscience, ACON Laboratories, Creative Diagnostics, BTNX, McKesson, Roche, Zoetis, BioMerieux.
The rapid diagnostic kits market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Rapid Diagnostic Kits Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Rapid Diagnostic Kits Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Rapid Diagnostic Kits Market - Supply Chain
4.5. Global Rapid Diagnostic Kits Market Forecast
4.5.1. Rapid Diagnostic Kits Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Rapid Diagnostic Kits Market Size (000 Units) and Y-o-Y Growth
4.5.3. Rapid Diagnostic Kits Market Absolute $ Opportunity
5. Global Rapid Diagnostic Kits Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Rapid Diagnostic Kits Market Size and Volume Forecast by Type
5.3.1. Lateral Flow Test
5.3.2. Agglutination Assays
5.3.3. Flow Through
5.3.4. Solid Phase
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Rapid Diagnostic Kits Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Rapid Diagnostic Kits Market Size and Volume Forecast by Application
6.3.1. Hospitals and Clinical Testing
6.3.2. Home Testing
6.3.3. Veterinary Testing
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Rapid Diagnostic Kits Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Rapid Diagnostic Kits Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Rapid Diagnostic Kits Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Rapid Diagnostic Kits Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Rapid Diagnostic Kits Demand Share Forecast, 2019-2026
9. North America Rapid Diagnostic Kits Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Rapid Diagnostic Kits Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Rapid Diagnostic Kits Market Size and Volume Forecast by Application
9.4.1. Hospitals and Clinical Testing
9.4.2. Home Testing
9.4.3. Veterinary Testing
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Rapid Diagnostic Kits Market Size and Volume Forecast by Type
9.7.1. Lateral Flow Test
9.7.2. Agglutination Assays
9.7.3. Flow Through
9.7.4. Solid Phase
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Rapid Diagnostic Kits Demand Share Forecast, 2019-2026
10. Latin America Rapid Diagnostic Kits Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Rapid Diagnostic Kits Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Rapid Diagnostic Kits Market Size and Volume Forecast by Application
10.4.1. Hospitals and Clinical Testing
10.4.2. Home Testing
10.4.3. Veterinary Testing
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Rapid Diagnostic Kits Market Size and Volume Forecast by Type
10.7.1. Lateral Flow Test
10.7.2. Agglutination Assays
10.7.3. Flow Through
10.7.4. Solid Phase
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Rapid Diagnostic Kits Demand Share Forecast, 2019-2026
11. Europe Rapid Diagnostic Kits Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Rapid Diagnostic Kits Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Rapid Diagnostic Kits Market Size and Volume Forecast by Application
11.4.1. Hospitals and Clinical Testing
11.4.2. Home Testing
11.4.3. Veterinary Testing
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Rapid Diagnostic Kits Market Size and Volume Forecast by Type
11.7.1. Lateral Flow Test
11.7.2. Agglutination Assays
11.7.3. Flow Through
11.7.4. Solid Phase
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Rapid Diagnostic Kits Demand Share, 2019-2026
12. Asia Pacific Rapid Diagnostic Kits Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Rapid Diagnostic Kits Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Rapid Diagnostic Kits Market Size and Volume Forecast by Application
12.4.1. Hospitals and Clinical Testing
12.4.2. Home Testing
12.4.3. Veterinary Testing
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Rapid Diagnostic Kits Market Size and Volume Forecast by Type
12.7.1. Lateral Flow Test
12.7.2. Agglutination Assays
12.7.3. Flow Through
12.7.4. Solid Phase
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Rapid Diagnostic Kits Demand Share, 2019-2026
13. Middle East & Africa Rapid Diagnostic Kits Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Rapid Diagnostic Kits Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Rapid Diagnostic Kits Market Size and Volume Forecast by Application
13.4.1. Hospitals and Clinical Testing
13.4.2. Home Testing
13.4.3. Veterinary Testing
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Rapid Diagnostic Kits Market Size and Volume Forecast by Type
13.7.1. Lateral Flow Test
13.7.2. Agglutination Assays
13.7.3. Flow Through
13.7.4. Solid Phase
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Rapid Diagnostic Kits Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Rapid Diagnostic Kits Market: Market Share Analysis
14.2. Rapid Diagnostic Kits Distributors and Customers
14.3. Rapid Diagnostic Kits Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Alfa Scientific Designs
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Artron Laboratories
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. BD
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Meridian Bioscience
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ACON Laboratories
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Creative Diagnostics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. BTNX
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. McKesson
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Roche
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Zoetis
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. BioMerieux
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
